Top Markets
Coin of the day
Innovation1 Biotech Inc. Innovation1 Biotech Inc.

Innovation1 Biotech Inc.

IVBT
Pozycja w akcjach #42121
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily... Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprietary prodrugs that are currently in preclinical development, each designed to tackle a unique set of medical conditions. Specifically, these include a psychedelic compound derived from mushrooms, aimed at treating post-traumatic stress disorder and depression; an innovative cannabinoid and tree bark-sourced psychedelic intended to combat addiction; and three additional cannabinoid prodrugs targeting refractory pediatric epilepsy, hypertrophic scarring, and inflammation of the eye. Established in 2014 and headquartered in New York, New York, the company was previously named Gridiron BioNutrients, Inc. before adopting its current moniker, Innovation1 Biotech Inc., in March 2022.
Cena akcji
$0.0002
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$4.49K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Innovation1 Biotech Inc. (IVBT)

Kategoria

Historia stopy dywidendy dla Innovation1 Biotech Inc. (IVBT)
Stopa dywidendy (TTM) dla Innovation1 Biotech Inc. (symbol akcji: IVBT) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Innovation1 Biotech Inc. (IVBT) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji